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Self-reactive CD4 T cells are incompletely deleted
during thymic development, and their peripheral
seeding highlights the need for additional safeguards
to avert autoimmunity. Here, we show an essential
role for the coinhibitory molecule programmed
death-1 (PD-1) in silencing the activation of high-af-
finity autoreactive CD4 T cells. Each wave of self-
reactive CD4 T cells that escapes thymic deletion
autonomously upregulates PD-1 to maintain self-
tolerance. By tracking the progeny derived from
individual autoreactive CD4 T cell clones, we de-
monstrate that self-reactive cells with the greatest
autoimmune threat and highest self-antigen affinity
express the most PD-1. Reciprocally, PD-1 depriva-
tion unleashes high-affinity self-reactive CD4 T cells
in target tissues to exacerbate neuronal inflammation
and autoimmune diabetes. Reliance on PD-1 to
actively maintain self-tolerance may explain why ex-
ploiting this pathway by cancerous cells and invasive
microbes efficiently subverts protective immunity,
and why autoimmune side effects can develop after
PD-1-neutralizing checkpoint therapies.
INTRODUCTION
Programmed death-1 (PD-1) is a coinhibitory molecule that fine-
tunes the balance between T cell activation, tolerance, and func-
tional exhaustion. Although PD-1 is transiently expressed by
activated T cells (Yamazaki et al., 2002), prolonged expression
with persistent cognate antigen stimulation has been classically
associated with functional exhaustion or hyporesponsiveness
(Barber et al., 2006; Day et al., 2006). This pivotal role of PD-1
in restricting T cell activation makes it an exciting molecular
target for therapeutically reactivating exhausted T cells duringCell Repo
This is an open access article under the CC BY-Npersistent infection or cancer. For example, PD-1 neutralization
is increasingly used as frontline therapy to counter immune
evasion by melanomas, lung cancers, and other solid tumors
(Garon et al., 2015; Robert et al., 2015; Topalian et al.,
2012). PD-1 blockade also reinvigorates functionally exhausted
T cells to augment immunity during chronic infection (Barber
et al., 2006; Day et al., 2006; Nakamoto et al., 2008). This conver-
gent exploitation of PD-1 by cancerous cells and invasive mi-
crobes underscores more essential roles for this immune check-
point molecule in maintaining immunological homeostasis.
The necessity for PD-1 in averting autoimmunity is supported
by several autoimmune adverse events including hypothyroid-
ism, colitis, diabetes, and pneumonitis triggered by PD-1 thera-
peutic blockade in cancer patients (Garon et al., 2015; Robert
et al., 2015; Topalian et al., 2012). Human polymorphisms that
diminish PD-1 activity similarly increase the risk of autoimmune
disorders such as systemic lupus erythematosus and multiple
sclerosis (Kroner et al., 2005; Prokunina et al., 2002). In turn,
mice deficient in PD-1 are also more susceptible to developing
a variety of autoimmune disorders including dilated cardiomyop-
athy, neuronal demyelination, diabetes, arthritis, and glomerulo-
nephritis (Nishimura et al., 1999, 2001; Rui et al., 2013; Wang
et al., 2005). Given this critical role for PD-1 in protection against
autoimmunity in humans and rodent disease models, we sought
to further investigate how this coinhibitory molecule controls the
activation and peripheral accumulation of autoreactive T cells.
Deletion of self-reactive T cells during thymic development is
essential for averting autoimmunity (Mathis and Benoist, 2009).
Active elimination of autoreactive T cells has been classically
shown through the selective deletion of self-reactive thymocytes
(Kappler et al., 1987). Similarly, near-complete purging of autor-
eactive T cell receptor (TCR)-transgenic CD4 and CD8 T cells
among mice expressing cognate self-antigen further reinforces
the necessity of central immune tolerance in protection against
autoimmunity (Anderson et al., 2005; Huseby et al., 2001; Kisie-
low et al., 1988). Residual self-reactive TCR-transgenic T cells
that survived thymic deletion also preferentially differentiate
into immune suppressive regulatory T cells (Tregs) to furtherrts 17, 1783–1794, November 8, 2016 ª 2016 The Author(s). 1783
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
reinforce self-tolerance (Bautista et al., 2009; Hsieh et al., 2006;
Leung et al., 2009). For example, the majority of peripheral CD4
T cells with fixed, high-affinity ovalbumin (OVA) specificity differ-
entiate into Foxp3+ Tregs when OVA is expressed in the
pancreas of RIP-mOVA-transgenic mice (Schmidt et al., 2009;
Walker et al., 2003). Similarly, 50% of monoclonal CD4
T cells with influenza hemagglutinin specificity differentiate into
CD25+ Tregs when this antigen is expressed as a self-antigen
in transgenic mice (Jordan et al., 2001). Interestingly, regulatory
T cell differentiation may be restricted to high-affinity self-reac-
tive CD4 T cells because low-affinity thymocytes with hemagglu-
tinin self-specificity do not preferentially undergo Treg differenti-
ation (Jordan et al., 2001), and <10% of thymocytes transduced
with low-affinity OVA-specific TCRs differentiate into Tregs in
RIP-mOVA mice (Lee et al., 2012). Thus, how tolerance is estab-
lished among naturally occurring autoreactive T cells that span a
wide range of affinities may not be accurately recapitulated with
TCR-transgenic models harboring abnormally high frequencies
of monoclonal T cells with fixed self-antigen affinity.
These limitations have been overcome with peptide:MHC II
tetramer staining and enrichment techniques that allow not
only identification of rare endogenous CD4 T cells based on
defined antigen specificity, but also quantitative analysis of their
affinity for cognate antigen based on the intensity of tetramer
binding (Malhotra et al., 2016; Moon et al., 2011; Nelson et al.,
2015; Rees et al., 1999). Interestingly, initial studies using this
approach show that deletion of autoreactive CD4 T cells is sur-
prisingly incomplete (Legoux et al., 2015; Maeda et al., 2014).
However, in contrast to robust induction of Tregs demonstrated
for high-affinity monoclonal T cells (Jordan et al., 2001; Schmidt
et al., 2009; Walker et al., 2003), only 10%–25% of endogenous
self-reactive CD4 T cells are Foxp3+ (Kinder et al., 2015; Legoux
et al., 2015; Moon et al., 2011). Appreciation that the majority of
endogenous autoreactive CD4 T cells that escape thymic dele-
tion are not Tregs opens up important questions regarding
how self-tolerance is maintained. By tracking the fate of individ-
ual self-reactive CD4 T cells from a polyclonal repertoire, we
show a necessity for PD-1 in culling peripheral high-affinity
autoreactive CD4 T cells that protects against autoimmunity.
These findings establish a framework that explains how the sur-
prising abundance of self-reactive T cells can harmoniously
coexist in peripheral tissues.
RESULTS
PD-1 Deprivation Preferentially Unleashes High-Affinity
Autoreactive CD4 T Cells to Exacerbate Autoimmunity
To investigate how PD-1 protects against autoimmunity, we first
analyzed CD4 T cells with specificity for myelin oligodendrocyte
glycoprotein (MOG) in C57BL/6 (B6) mice. Activated CD4 T cells
with this specificity cause neuronal demyelination and paralysis
representative of human multiple sclerosis in preclinical models
of experimental autoimmune encephalomyelitis (EAE) (Miller and
Karpus, 2007; Rangachari and Kuchroo, 2013). We and others
have shown that tolerance to MOG is inherently incomplete as
MOG-specific CD4 T cells from MOG-deficient compared with
wild-type mice respond near identically after cognate antigen
stimulation (Figure S1A) (Delarasse et al., 2003). This incomplete1784 Cell Reports 17, 1783–1794, November 8, 2016tolerance likely stems from the tissue-restricted nature of MOG
expression, and is not an intrinsic property of MOG-reactive
CD4 T cells because engineering ubiquitous MOG expression
under the b-actin promoter (Act-MOG-transgenic mice; Fig-
ure S1B) or in the bone marrow progenitor stem cells (Chan
et al., 2008), restores self-tolerance and eliminates the enceph-
alitogenic potential of MOG-specific CD4 T cells (Figures S1A–
S1D). Thus, naturally incomplete tolerance to MOG in wild-type
mice renders it ideal for probing the peripheral safeguards that
reinforce self-tolerance.
Prior to exogenous stimulation with cognate self-antigen, we
found that PD-1 expression by peripheral MOG-specific CD4
T cells directly correlated with their affinity for cognate self-anti-
gen based on MOG:I-Ab tetramer staining intensity (Figure 1A)
(Malhotra et al., 2016; Moon et al., 2011; Nelson et al., 2015).
In the absence of PD-1, the number of MOG-specific CD4
T cells in peripheral lymphoid tissues was significantly increased
(Figure S1D). These changes occurred selectively among periph-
eral autoreactive T cells because no significant differences in
MOG-specific CD4 T cells were found among thymocytes, or
among peripheral CD4 T cells with foreign microbial specificity
(Figures S1E and S1F). In turn, infiltration of the brain and spinal
cord by autoreactive CD4 T cells with the highest MOG affinity
was unleashed in PD-1-deficient mice after MOG administration
in complete Freund’s adjuvant (Figures 1B and S2). This neces-
sity for PD-1 in dampening the activation of high-affinity self-
reactive CD4 T cells likely explains why the severity and
incidence of EAE are both sharply exacerbated in the absence
of PD-1 (Figure 1C) (Rui et al., 2013; Salama et al., 2003).
To determine whether suppressed activation of autoreactive
CD4 T cells by PD-1 extends to other types of autoimmunity,
self-reactive CD4 T cells were evaluated in non-obese diabetic
(NOD) mice that spontaneously develop autoimmune diabetes
(Anderson and Bluestone, 2005). Analogous to MOG-specific
CD4 T cells, the highest affinity autoreactive CD4 T cells with
specificities to two distinct islet antigens (chromogranin A mim-
etope p31 and insulin) expressed the most PD-1 (Figures 1D,
1E, and S2) (Judkowski et al., 2001; Pauken et al., 2013). In
turn, PD-1 deprivation triggered robust pancreatic accumula-
tion of high-affinity insulin-specific CD4 T cells (Figure 1F) and
accelerated onset of autoimmune diabetes (Figure 1G) (Ansari
et al., 2003; Wang et al., 2005). Thus, pathological infiltration
and tissue accumulation of high-affinity autoreactive cells
triggered by PD-1 deprivation in these complementary disease
models highlight the importance of PD-1 in selectively silencing
the activation of high-affinity self-reactive CD4 T cells to deter
autoimmunity.
Peripheral Accumulation of Autoreactive High-Affinity
CD4 T Cells with Self-Antigen Stimulation
Because individual T cells are stochastically released from
the thymus throughout life (Hale et al., 2006), the peripheral
pool of endogenous autoreactive T cells is heterogeneous with
regard to each cell’s duration of prior self-antigen exposure.
Accordingly, early phenotypic shifts that program self-tolerance
among individual T cell clones after encountering cognate anti-
gen are likely masked when evaluating the endogenous pool of
autoreactive cells at any fixed postnatal time point. To more
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Figure 1. PD-1 Deprivation Unleashes High-Affinity Self-Reactive CD4 T Cells to Exacerbate Autoimmunity
(A) MOG:I-Ab tetramer mean fluorescence intensity (MFI) and PD-1 expression levels for MOG-specific CD4 T cells pooled from spleen and peripheral lymph
nodes in 6- to 8-week-old naive B6 mice. Each data point represents the average tetramer and PD-1 staining intensity for cells from an individual mouse prior to
exogenous MOG peptide stimulation.
(B) Number of MOG-specific CD4 T cells, and their intensity of MOG:I-Ab tetramer staining, recovered from pooled brain and spinal cords of PD-1-deficient
compared with wild-type mice 14 days after immunization with MOG35-55 peptide in complete Freund’s adjuvant (CFA).
(C) EAE incidence (p < 0.001) and clinical score after immunization with MOG peptide with CFA for PD-1-deficient compared with wild-type mice.
(D) p31:I-Ag7 tetramer MFI and PD-1 expression levels for peripheral chromogranin A-specific CD4 T cells pooled from the spleen and peripheral lymph nodes of
13- to 16-week-old NOD mice.
(E) Insulin:I-Ag7 tetramer MFI and PD-1 expression levels for peripheral insulin-specific CD4 T cells pooled from the spleen and peripheral lymph nodes of 15- to
18-week-old NOD mice.
(F) Number of insulin-specific CD4 T cells, and their intensity of insulin:I-Ag7 tetramer staining, recovered from the pancreas of 5-week-old NODmice treated with
PD-1-neutralizing antibody or controls. Animals lacking insulin-specific CD4 T cells in the pancreas were not included in the analysis of insulin:I-Ag7 tetramer
staining intensity.
(G) Diabetes onset incidence (p < 0.0001) for PD-1-deficient compared with wild-type mice on the NOD background. The error bar represents 1 SEM. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001, using non-parametric Mann-Whitney U test.
See also Figures S1 and S2.deliberately investigate the synchronized response of autoreac-
tive T cells to peripheral self-antigen stimulation, one donor
equivalent polyclonal endogenous CD4 T cells with 2W1S:I-Ab
specificity from naive B6 mice were tracked after transfer into
isogenic Act-2W1S recipients that ubiquitously express the
2W1S peptide in all cells under the b-actin promoter (Figure 2A)
(Moon et al., 2011). Despite ubiquitous expression of 2W1S in all
cells, the high number of 2W1S-specific CD4 T cells (100 cells
per mouse) that persist underscore existing knowledge gaps
regarding how these self-reactive T cells coexist within tissues
constitutively expressing cognate self-antigen (Kinder et al.,
2015; Moon et al., 2011). We reasoned that, because 2W1S is
a genetically foreign antigen in donor B6 mice, the response of
their 2W1S-specific CD4 T cells to cognate antigen in Act-
2W1S recipients can be used to investigate how autoreactive
T cells that escape thymic deletion respond to self-antigen in pe-
ripheral tissues. In turn, the high frequency of endogenous CD4
T cells with 2W1S:I-Ab specificity compared with other I-Ab-
restricted specificities (e.g., OVA323-339, FliC427-441) allows donor
cells to be readily identified after transfer (Moon et al., 2007;
Nelson et al., 2015).Using this model to track polyclonal autoreactive T cells after
synchronized exposure to cognate self-antigen, we show that
donor CD4 T cells with 2W1S specificity sharply expand by
approximately 100-fold within the first week (Figure 2B). Along
with expansion, autoreactive donor 2W1S-specific CD4 T cells
become uniformly antigen experienced based on increased
CD44 expression, and enriched for cells of the highest self-anti-
gen affinity based on the intensity of 2W1S:I-Ab tetramer staining
(Figure 2C). Self-reactive CD4 T cells with the highest 2W1S:I-Ab
tetramer staining intensity had reciprocally reduced TCR expres-
sion based on anti-CD3 staining levels (Figure 2C), demon-
strating the selective accumulation of autoreactive T cells with
high-affinity self-reactive TCRs. Near-identical expansion of
autoreactive CD4 T cells with high 2W1S:I-Ab affinity was found
after restricting the analysis to antigen-experienced CD44+ cells
(Figure S3). Importantly, expanded accumulation of high-affinity
autoreactive cells reflects the primary response of naive CD4
T cells to cognate self-antigen stimulation, and could not be
explained by non-specific shifts associated with transfer into
Act-2W1S recipients, because no significant shifts in expansion,
CD44 expression, or TCR affinity were found among CD4 T cellsCell Reports 17, 1783–1794, November 8, 2016 1785
W
T 
D
on
or
  
(C
D
45
.2
) 
Recipient 
(CD45.1) 
WT donor  
CD4 cells 
(CD45.2) 
Act-2W1S 
(CD45.1) 
D1 D8 D30 D3 
C
D
44
 
2W1S:I-Ab
0 10 20 30
100
101
102
103
104
Days post transfer
2W
1S
+  C
D
4 
ce
lls
 (#
) Recipient
Donor
C
D
44
 
2W1S:I-Ab
A 
C 
Pr
e-t
ran
sfe
r
Po
st-
tra
ns
fer
 (D
8)
Re
cip
ien
t
0
25
50
75
100
C
D
44
+  (
%
)
Pr
e-t
ran
sfe
r
Po
st-
tra
ns
fer
 (D
8)
Re
cip
ien
t
0
1500
3000
4500
6000
2W
1S
:I-
A
b  (
M
FI
)
Pr
e-t
ran
sfe
r
Po
st-
tra
ns
fer
 (D
8)
Re
cip
ien
t
0
1000
2000
3000
4000
C
D
3 
(M
FI
)
Pr
e-t
ran
sfe
r
Po
st-
tra
ns
fer
 (D
8)
Re
cip
ien
t
0.0
2.5
5.0
7.5
10.0
2W
1S
:I-
A
b  (
TC
R
 a
ffi
ni
ty
)
Recipient
Donor
B 
Figure 2. Activation and Expansion of High-Affinity CD4 T Cells following Cognate Self-Antigen Stimulation
(A) Schematic used to identify donor (CD45.2) self-reactive CD4 T cells with 2W1S:I-Ab specificity in CD45.1 recipient mice that ubiquitously express 2W1S as a
transmembrane recombinant protein in all cells under the b-actin promoter (Act-2W1S mice).
(B) Representative fluorescence-activated cell sorting (FACS) plots and composite analyses of CD4 T cells with 2W1S:I-Ab specificity recovered from the spleen
and peripheral lymph nodes of Act-2W1S recipients at the indicated time points after intravenous transfer of 107 donor (CD45.2) CD4 T cells.
(C) Percent CD44+, 2W1S:I-Ab tetramer MFI, CD3 MFI, and 2W1S:I-Ab TCR affinity (tetramer MFI divided by CD3 MFI) for donor 2W1S-specific CD4 T cells
pre- and post-transfer, compared with cells of the same specificity in recipient mice. The error bar represents 1 SEM.
See also Figures S3 and S4.from Act-2W1S donors transferred into congenically discordant
Act-2W1S recipients (Figure S4). Thus, high-affinity autoreactive
T cells rapidly accumulate following synchronized stimulation
with cognate self-antigen in peripheral tissues.
Activated Autoreactive CD4 T Cells Are Intrinsically
Programmed to Become Self-Tolerant
To investigate the functional properties of autoreactive CD4
T cells, their activation after cognate antigen stimulation under
highly inflammatory conditionswas evaluated.Weused an atten-
uated recombinant Listeria monocytogenes expressing 2W1S
(Lm-2W1S) to probe the responsiveness of self-reactive 2W1S-
specific T cells (Ertelt et al., 2009). In contrast to robust expansion
of donor CD4 T cells with 2W1S specificity in B6 recipient mice
after Lm-2W1S infection, the same antigen-specific donor popu-
lation failed to respond in Act-2W1S recipients (Figures 3A and
3B). This acquired tolerance phenotype was restricted to 2W1S
self-antigen-experienced CD4 T cells because donor cells with
specificity to the genetically foreign Listeria-encoded peptide
(LLO189-201) expanded equally in wild-type and Act-2W1S recip-1786 Cell Reports 17, 1783–1794, November 8, 2016ients (Figure 3B). In addition to blunted overall expansion, pro-in-
flammatory cytokine production (i.e., IFN-g, IL-2) was also selec-
tively diminished for donor CD44+ 2W1S-specific CD4 T cells
compared with donor cells of irrelevant specificity (Figures 3C
and 3D). Thus, despite an initial expansion burst of high-affinity
self-reactive CD4 T cells, these cells are efficiently programmed
to adopt a self-tolerant phenotype.
Cell-Intrinsic PD-1 Expression Reinforces Tolerance
among Self-Reactive CD4 T Cells
To further investigate cell-intrinsic mechanism(s) maintaining
self-tolerance, expression of molecules associated with func-
tional anergy was evaluated among autoreactive T cells. Autor-
eactive donor CD4 T cells with 2W1S:I-Ab specificity upregulated
PD-1, CD73, and folate receptor 4 (FR4) compared to bulk CD4
T cells (Kalekar et al., 2016; Martinez et al., 2012; Pauken et al.,
2013) (Figure 4A). Conversely, there were only minimal to no
changes in expression of other T cell inhibitory markers. Interest-
ingly, self-tolerant 2W1S-specific CD4 T cells were not enriched
for expression of the regulatory T cell lineage-defining marker
AC D
B
Figure 3. Autoreactive CD4 T Cells Acquire Self-Tolerance in Response to Cognate Antigen Stimulation in Peripheral Tissues
(A) Schematic for probing the response of donor self-reactive CD4 T cells with 2W1S:I-Ab specificity to Lm-2W1S priming within congenically discordant Act-
2W1S recipients.
(B) Number of donor (CD45.2) 2W1S-specific CD4 T cells recovered following transfer into wild-type or Act-2W1S CD45.1 recipient mice 8 days after Lm-2W1S
challenge compared with no-infection naive control mice.
(C) Schematic showing ex vivo stimulation of donor self-reactive CD4 T cells with 2W1S:I-Ab specificity recovered from Act-2W1S recipient mice.
(D) Representative FACS plots and composite analysis comparing IFN-g and IL-2 production between CD4 T cells with self-2W1S or irrelevant bulk specificity
after PMA-ionomycin stimulation. The error bar represents 1 SEM. **p < 0.01, ***p < 0.001, ****p < 0.0001, using non-parametric Mann-Whitney U test.Foxp3, in agreement with recent findings that the majority of
endogenous autoreactive CD4 T cells that escape thymic dele-
tion are not Tregs (Figure 4A) (Legoux et al., 2015; Moon et al.,
2011).
To address the necessity for cell-intrinsic PD-1 expression
in mediating self-tolerance among autoreactive T cells, we
compared the phenotype of donor CD4 T cells from PD-1-defi-
cient and wild-type mice after adoptive transfer into Act-2W1S
recipients. PD-1 was essential for maintaining self-tolerance
because Lm-2W1S stimulation induced significant expansion
of PD-1-deficient, but not wild-type donor CD4 T cells with
2W1S:I-Ab specificity (Figure 4B). To further validate that cell-
intrinsic reprogramming is responsible for this self-tolerant
phenotype, autoreactive CD4 T cells were transferred from their
tolerogenic environment into recipients that lack 2W1S self-anti-
gen expression (Figure 5A). Despite secondary transfer into wild-
type recipients, donor 2W1S-specific CD4 T cells remained re-
fractory to Lm-2W1S stimulation yet retained PD-1 expression
(Figures 5B and 5C). Furthermore, this self-tolerant phenotype
persisted even under lymphopenic conditions because tolerized
2W1S-specific CD4 T cells also failed to expand after Lm-2W1Spriming both during and after homeostatic proliferation in irradi-
ated recipients (Figures 5D, 5E, and S5). Persistent self-toler-
ance despite lymphopenia-induced proliferation was also not
reflective of maturing regulatory T cell precursors because there
were no significant shifts in Foxp3, CD73, or FR4 expression
(Figure S6) (Kalekar et al., 2016). Instead, self-reactive CD4
T cells with 2W1S:I-Ab specificity selectively retained PD-1
expression under lymphopenic conditions (Figure 5F).
Given the stochastic peripheral seeding of self-reactive T cell
clones that escape thymic deletion throughout postnatal devel-
opment, we next examined how a preexisting pool of expanded,
high-affinity autoreactive CD4 T cells impacts self-tolerance
acquisition for a subsequent wave of escaped T cells with over-
lapping self-antigen specificity (Figure 6A). Remarkably, we find
that a secondary wave of autoreactive donor cells still expands
and becomes enriched for cells with high-intensity tetramer
staining and PD-1 expression, despite the presence of preexist-
ing high-affinity autoreactive CD4 T cells (Figures 6B and 6C). In
other words, individual clones of self-reactive T cells expand
and upregulate PD-1 autonomously after cognate self-antigen
stimulation in peripheral tissues.Cell Reports 17, 1783–1794, November 8, 2016 1787
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Figure 4. PD-1 Reinforces Self-Tolerance
among Self-Reactive CD4 T Cells
(A) Cell-intrinsic expression of each molecule by
donor self-reactive CD4 T cells with 2W1S:I-Ab
specificity (black line) compared with irrelevant
bulk specificity (shaded), 30 days after transfer into
Act-2W1S recipients.
(B) Schematic illustrating adoptive transfer of
donor PD-1-deficient or wild-type CD4 T cells
into Act-2W1S recipients, followed by Lm-2W1S
challenge 30 days after transfer; and number of
donor self-reactive CD4 T cells with 2W1S:I-Ab
specificity in spleen and peripheral lymph nodes of
mice 8 days after Lm-2W1S challenge compared
with no-infection naive control mice. The error bar
represents 1 SEM. ****p < 0.0001, using non-
parametric Mann-Whitney U test.PD-1 Controls Clonal Burst Size and TCR Affinity for
Individual Self-Reactive CD4 T Cells
Because endogenous polyclonal T cell clones can recognize
the same antigen with diverse TCRs that span a wide range of
affinities, self-reactive T cells that stochastically escape thymic
deletion likely vary in autoimmune potential, and in their require-
ments for additional peripheral safeguards. Accordingly, our
model to track polyclonal autoreactive T cells was refined to
investigate potential differences in how each individual self-
reactive CD4 T cell clone responds to cognate antigen in pe-
ripheral tissues. We transferred limiting numbers of endoge-
nous T cells from non-transgenic donor mice so that each
Act-2W1S recipient contains, on average, less than one CD4
T cell with 2W1S:I-Ab specificity (Figure S7) (Taswell, 1981;
Tubo et al., 2013). Using this approach, we found that individual
self-reactive CD4 T cell clones with the highest TCR affinity and
greatest expansion burst express the most PD-1 (Figures 7A
and 7B; Table S1).
To more definitively investigate the role of PD-1 in shaping
the peripheral self-reactive T cell repertoire, the progeny of in-
dividual self-reactive PD-1-deficient compared with wild-type
polyclonal CD4 T cell clones were tracked after transfer into
Act-2W1S recipients. Clonal burst size and TCR affinity for
2W1S self-antigen sharply increased among self-reactive
progenies derived from PD-1-deficient compared with wild-
type donors (Figures 7C and 7D; Table S1). Importantly, clonal
burst size and TCR affinity were simultaneously unleashed in
the absence of PD-1 among autoreactive CD4 T cells (Fig-
ure 7E). Thus, cell-intrinsic PD-1 expression is essential for
culling the peripheral repertoire of high-affinity autoreactive
CD4 T cells.1788 Cell Reports 17, 1783–1794, November 8, 2016DISCUSSION
Newly refined peptide:MHC II tetramer
staining and enrichment techniques
show the surprising presence of autor-
eactive CD4 T cells in the endogenous
peripheral repertoire (Legoux et al.,
2015; Maeda et al., 2014; Malhotra
et al., 2016; Moon et al., 2011). Theintrinsic leakiness in deletion of self-reactive T cell clones during
thymic development highlights important knowledge gaps
regarding how autoreactive T cells can harmoniously coexist in
peripheral tissues without causing autoimmunity. Given the sto-
chastic peripheral seeding of T cells from the thymus that varies
the duration of each self-reactive cell’s exposure to cognate an-
tigen, analysis of endogenous CD4 T cells of self-specificity at
any specific postnatal time point using peptide:MHC class II tet-
ramers still fails to account for this important point of heteroge-
neity among peripheral self-reactive CD4 T cells. To overcome
these limitations, donor CD4 T cells derived from an endogenous
polyclonal repertoire were tracked after adoptive transfer into
transgenic recipients expressing a defined model self-antigen.
Surprisingly, this strategy revealed that >90% of autoreactive
CD4 T cells remained Foxp3 effectors and were not regulatory
T cell precursors, despite uniform enrichment of high-affinity
TCRs. Instead, self-reactive CD4 T cells acquired cell-intrinsic
tolerance through expression of the immune checkpoint mole-
cule PD-1. PD-1 upregulation by self-reactive CD4 T cells
occurred in a cell-autonomous fashion, despite the presence
of preexisting cells with specificity for the same self-antigen.
Each individual CD4 T cell among a naive polyclonal repertoire
with specificity for the same peptide antigen likely utilizes unique
TCRs with varying signal strength. Therefore, whether the uni-
form upregulation of TCR affinity and PD-1 observed for poly-
clonal donor CD4 T cells reflects the dominant response of a
few high-affinity clones or more global participation by all clones
remained undefined. To investigate this important relationship
between TCR affinity, peripheral clonal expansion, and PD-1
expression for individual autoreactive CD4 T cells, we used a sin-
gle-cell transfer approach to track the progeny of individual
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Figure 5. PD-1 Expression Promotes Durable Cell-Intrinsic Self-Tolerance among Self-Reactive CD4 T Cells
(A) Schematic showing initial transfer of onemouse equivalent donor CD45.2 CD4 T cells (107 cells) into Act-2W1SCD45.1 recipients, with secondary transfer into
wild-type recipients followed by Lm-2W1S priming.
(B) Donor 2W1S-specific CD4 T cells in the spleen and peripheral lymph nodes 8 days after Lm-2W1S challenge compared with no-infection naive control mice.
(C) PD-1 expression by CD4 T cells with 2W1S (black line) or irrelevant bulk (shaded) for the mice described in (A) and (B).
(D) Schematic showing initial transfer of onemouse equivalent donor CD45.2 CD4 T cells (107 cells) into Act-2W1SCD45.1 recipient mice, and secondary transfer
into irradiated wild-type recipients followed by Lm-2W1S challenge after 15–20 days (HP) or >100 days (post-HP).
(E) Donor 2W1S-specific CD4 T cells recovered from the spleen and peripheral lymph nodes enumerated 8 days post Lm-2W1S challenge compared with no-
infection naive control mice.
(F) PD-1 expression by CD4 T cells with 2W1S (black line) or irrelevant bulk (shaded) specificity for the mice described in (D) and (E). The error bar represents 1
SEM. *p < 0.05, using non-parametric Mann-Whitney U test.
See also Figures S5 and S6.autoreactive CD4 T cell clones. We found that self-reactive CD4
T cell progenies with the greatest expansion burst size and high-
est TCR affinity expressed the most PD-1. We hypothesize that
each self-reactive CD4 T cell’s affinity for self-antigen serves
as an internal rheostat to control the level of PD-1 expression
necessary to acquire self-tolerance. Conversely, reliance on
PD-1 proportionally based on self-reactive TCR affinity may
normalize the autoimmune threat posed by CD4 T cell clones
that span a wide range of self-antigen affinities (Bettini et al.,
2014).
Our findings also highlight the necessity for PD-1 in restraining
the activation of peripheral CD4 T cells, similar to what has been
described for self-reactive CD8 T cells (Probst et al., 2005). In this
regard, contraction of donor self-reactive cells has been inter-
preted as a mechanism for preventing autoimmunity by CD8
T cells (Kurts et al., 1997), and we find similar contraction magni-
tude and kinetics for self-reactive CD4 T cells after an initial
expansion burst. Despite these numerical reductions, there re-
mains a formidable pool of residual autoreactive T cells that differ
in tolerance durability. For example, self-tolerance for CD8
T cells with viral (GAG) specificity acquired after adoptive trans-
fer into transgenicmice whereGAG is expressed by hepatocytes
is readily reversed during lymphopenia-induced homeostaticproliferation (Schietinger et al., 2012). Similarly, and despite
persistent upregulation of cell-intrinsic PD-1 expression, func-
tionally exhausted CD8 T cells primed by chronic lymphocytic
choriomeningitis virus (LCMV) infection can reacquire prolifera-
tive capacity in the absence of cognate antigen stimulation
(Utzschneider et al., 2013). By contrast to these examples of
reversible CD8 T cell tolerance and functional exhaustion, we
show self-tolerance for autoreactive CD4 T cells is sustained
during lymphopenia and maintained despite withdrawal of
cognate antigen stimulation. These differences in the establish-
ment and durability of functional tolerance between CD4 and
CD8 T cells may reflect selective stimulation through unique
PD-1 ligands. For example, although functional tolerance for
CD8 T cells is primarily mediated by PD-1 interacting with PD-
L1 (Probst et al., 2005), PD-1 signaling through both PD-L1
and PD-L2 have been implicated in maintaining quiescence of
self-reactive CD4 T cells (Carter et al., 2007; Cheng et al.,
2007; Salama et al., 2003; Schreiner et al., 2008; Zhu et al.,
2006). Thus, dissecting the molecular basis for how self-toler-
ance is discordantly established between CD4 and CD8
T cells, along with how PD-1:PD-L2 interactions may selectively
reinforce self-tolerance among CD4 T cells are important areas
for future investigation.Cell Reports 17, 1783–1794, November 8, 2016 1789
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Figure 6. An Initial Wave of Self-Reactive T Cells That Bypass Clonal Deletion Does Not Impede the Expansion and Activation of Subsequent
Self-Reactive Cells with Overlapping Specificity
(A) Schematic showing two distinct cohorts of congenically discordant donor CD4 T cells (one mouse equivalent, 107 each donor cell type) transferred into the
same Act-2W1S recipient mouse 30 days apart.
(B) Accumulation of self-reactive CD4 T cells with 2W1S:I-Ab specificity from each donor subset in Act-2W1S recipients.
(C) Comparison of 2W1S:I-Ab tetramer staining intensity and PD-1 expression among 2W1S-specific CD4 T cells from each donor subset or recipient mice at the
indicated time points posttransfer. The error bar represents 1 SEM.In the broader clinical context, our findings illustrating the ne-
cessity for PD-1 in deterring autoimmune disease shed light on
why PD-1 neutralization during tumor treatment often triggers
adverse autoimmune side effects (Garon et al., 2015; Robert
et al., 2015; Topalian et al., 2012). Because self-reactive T cells
are continuously seeded by the thymus throughout life, PD-1
may be especially critical for reinforcing self-tolerance in the
elderly that have accrued the largest pool of autoreactive cells.
Longitudinal studies in mice have reported that, with age, CD4
T cells become increasingly antigen experienced, enriched for
PD-1, and acquire a state of hyporesponsiveness (Shimatani
et al., 2009). A consequence of age-associated PD-1 reliance
would be impaired responsiveness to cross-reactive antigens
expressed by tumors, which may explain why the elderly experi-
ence a precipitous rise in cancer incidence (Gro¨nberg, 2003), but
a reciprocal decline in the emergence of prototypical autoim-
mune disorders (i.e., multiple sclerosis, type 1 diabetes) (Leslie
and Delli Castelli, 2004; Mayr et al., 2003).
Robust PD-1 expression driving functional exhaustion of
antigen-specific T cells is also a hallmark of persistent dis-
orders caused by pathogens (e.g., human immunodeficiency vi-
rus [HIV], LCMV) (Barber et al., 2006; Day et al., 2006; Nakamoto
et al., 2008). However, because the functional properties of PD-1
have been extensively probed for T cells with tumor or foreign
microbial specificity, how this pathway protects against autoim-
munity and the activation of autoreactive T cells remain less
clearly defined. Variability in autoimmune disease severity influ-
enced by mouse strain background, housing conditions, and
potentially other undefined factors, along with isolated examples
of PD-1-independent T cell exhaustion, further contribute to this
uncertainty (Nishimura et al., 1999, 2001; Odorizzi et al., 2015).1790 Cell Reports 17, 1783–1794, November 8, 2016Nevertheless, we reasoned that PD-1 signaling must have an
indispensable role for reinforcing self-tolerance, as tumors and
pathogens that each establish persistent disease have con-
verged to co-opt this pathway. Indeed, eliminating PD-1
signaling unleashed accumulation of high-affinity CD4 T cells
with tissue specificity, which paralleled increased susceptibility
to neuronal inflammation and autoimmune diabetes. Thus, this
persistent necessity for PD-1 in culling high-affinity autoreactive
CD4 T cells fills critical knowledge gaps regarding why auto-
immune side effects result from PD-1 neutralization, and why
tumors and pathogens have converged to co-opt this pathway
to subvert host defense and establish persistence.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) and B6-LY5.1 (CD45.1) mice were purchased from the National
Cancer Institute. B6.RAG1/micewere purchased fromThe Jackson Labora-
tory. B6.Act-2W1S-transgenic mice were a gift from Dr. Marc Jenkins (Univer-
sity ofMinnesota) (Moon et al., 2011). B6.MOG/micewere a gift fromDr. Gu-
rumoorthy Krishnamoorthy (Max Planck Institute). B6.PD-1/mice were a gift
from Dr. Tasuku Honjo (Kyoto University). B6.PD-1/mice were backcrossed
13 generations to NOD to generate NOD.PD-1/. B6.Act-MOG mice were
engineered by replacing the coding sequence for 2W1S peptide with the cod-
ing sequence for MOG35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) (Moon
et al., 2011). NOD mice were purchased from Taconic. All experiments were
conducted under Cincinnati Children’s Hospital or University of Minnesota
Institutional Animal Care and Use Committee-approved protocols.
PD-1 Pathway Blockade
Mice were given 250 mg of anti-PD-1 antibody (clone J43; BioXCell) intraperi-
toneally every other day for five injections prior to harvest and compared to
untreated controls.
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Figure 7. PD-1 Dampens Peripheral Accumulation of Individual Autoreactive CD4 T Cell Clones Based on TCR Self-Antigen Affinity
(A) Schematic showing transfer of individual donor CD4 T cells with 2W1S:I-Ab specificity into congenically discordant Act-2W1S recipients.
(B) Correlation between PD-1MFI and clonal burst size, and between PD-1MFI and 2W1S:I-Ab TCR affinity, for each self-reactive CD4 T cell clone derived from a
polyclonal repertoire.
(C) Schematic showing transfer of individual CD4 T cells with 2W1S:I-Ab specificity from either wild-type or PD-1-deficient donors into congenically discordant
Act-2W1S recipients.
(D) Clonal burst size and 2W1S:I-Ab TCR affinity for individual self-reactive CD4 T cell clones with or without cell-intrinsic PD-1 expression 8 days after transfer.
(E) Two-dimensional analysis of clonal burst size and TCR affinity for individual donor CD4 T cell clones with 2W1S:I-Ab specificity described in (C) and (D). The
error bar represents 1 SEM. *p < 0.05, **p < 0.01, using non-parametric Mann-Whitney U test for (D) and multivariable ANOVA for (E).
See also Figure S7 and Table S1.Experimental Autoimmune Encephalomyelitis
Mice were subcutaneously injected with MOG35-55 peptide (100 mg) emulsified
in complete Freund’s adjuvant. Clinical signs of EAE were assessed according
to the following scale: 0, no signs of disease; 1, flaccid tail; 2, hind-limb weak-
ness; 3, hind-limb paralysis; 4, tetraplegia; 5, moribund (Fife et al., 2001; Miller
and Karpus, 2007; Rangachari and Kuchroo, 2013).
Tetramer-Based Cell Enrichment and Flow Cytometry
Single-cell suspensions from the spleen, secondary lymph nodes, or thymi
were acquired by mechanical disruption, stained with phycoerythrin (PE)-
and/or allophycocyanin (APC)-conjugated tetramers (1 hr, room tempera-
ture), and then enriched using magnetic beads and columns as described
(Moon et al., 2007). Samples were acquired on a BD FACSCanto or LSR
II Fortessa, and analyzed with FlowJo software (Tree Star). MOG35-55:I-A
b
and influenza A virus NP311-325:I-A
b-specific CD4 T cells were gated on lym-
phocytes, single cells, B cell and myeloid (B220, CD8a, CD11b, CD11c, F4/
80)-negative, CD3+CD4+CD8 tetramer-positive cells (Figure S2). p31:I-Ag7
(YVRPLWVRME) and InsB10-23:I-A
g7 (HLVERLYLVCGEEG)-specific CD4
T cells were gated on lymphocytes, single cells, B cell and myeloid
(B220, CD8a, CD11b, CD11c)-negative, CD3+CD4+CD8 tetramer double-
positive (PE and APC) cells, as previously described (Judkowski et al.,
2001; Pauken et al., 2013). Tetramer geometric mean fluorescence intensity
(MFI) was calculated in FlowJo by gating on tetramer+ CD4 T cells. TCR
affinity was calculated as follows: (tetramer geometric MFI)/(CD3ε geo-
metric MFI).Isolation of CNS and Pancreas-Infiltrating Lymphocytes
The brain and spinal cords were mashed between frosted glass slides, passed
throughacell strainer, andpelleted in40%Percoll. Lymphocyteswerewashed,
suspended in saline, and stained with MOG:I-Ab tetramer. Pancreata were di-
gested with 0.8 mg/ml collagenase P andmashed through a cell strainer. Lym-
phocytes were isolated using a discontinuous Percoll gradient (44%/67%) and
stained with insulinB10-23:I-A
g7 tetramers as described (Pauken et al., 2013).
Cytokine Production
Splenocytes and lymph node cells were stimulated with PMA (81 nM) and
ionomycin (1.3 mM) (eBioscience) in media supplemented with brefeldin A for
4–5 hr at 37C.
Listeria monocytogenes
Attenuated recombinant Listeria monocytogenes expressing the 2W1S pep-
tide (Lm-2W1S) was cultured in brain-heart infusion media at 37C, back-
diluted to log-phase growth (OD600 = 0.1), washed, and suspended in sterile
saline prior to intravenous inoculation (107 colony-forming units per mouse)
(Ertelt et al., 2009).
Sublethal Irradiation and Reconstitution
Lymphopenia was induced in 6- to 8-week-old mice by sublethal irradiation
(500 rad). The following day, single-cell suspensions of spleen and lymph
node cells (108) from congenically discordant donor mice were intravenously
injected.Cell Reports 17, 1783–1794, November 8, 2016 1791
Transfer of Single Autoreactive T Cells
To track individual self-reactive CD4 T cell clones, donor cells from congeni-
cally discordant B6 or PD-1-deficient mice were intravenously administered
into Act-2W1S recipients, such that on average each recipient received less
than one CD4 T cell with 2W1S specificity. The frequency of recipient mice
containing donor cell-derived progenies, and their monoclonal origin likelihood
were retroactively calculated by the Poisson model (Figure S6B; Table S1)
(Taswell, 1981; Tubo et al., 2013).
Statistical Analysis
All statistical analysis with the exception of themultivariate analysis of variance
(MANOVA) was performed with Prism (GraphPad). MANOVA tests were per-
formed with MATLAB (MathWorks).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and two tables and can be
foundwith this article online at http://dx.doi.org/10.1016/j.celrep.2016.10.042.
AUTHOR CONTRIBUTIONS
T.T.J., T.M., L.X., J.M.K., J.A.S., B.T.F., and S.S.W. performed or participated
in data acquisition and analysis. T.T.J., T.M., B.T.F., and S.S.W. conceived of
these experiments and wrote the paper with editorial input from all of the au-
thors. B.T.F. supervised the experiments related to autoimmune diabetes
and tracking pancreas-specific CD4 T cells. S.S.W. supervised the experi-
ments related to EAE autoimmunity and tracking CD4 T cells with all other
specificities.
ACKNOWLEDGMENTS
We thank Drs. Theresa Alenghat, Hitesh Deshmukh, David Haslam, David
Hildeman, Jonathan Katz, and Joseph Qualls for helpful discussions; Dr. Baolin
Wu for help with statistical analysis; Linnea Swanson and Nathanael Sahli for
technical assistance; and the NIH Tetramer Core Facility (Contract
HHSN272201300006C) for provision of class II MHC tetramers (MOG35-55:I-A
b,
influenza A virus NP311-325:I-A
b). This work was supported by NIH Grants F30-
DK107199 and T32-GM063483 (T.T.J.), R01-AI106791 (B.T.F.), and R01-
AI120202 (S.S.W.); Juvenile Diabetes Research Foundation Grant 2-2011-662
(to B.T.F.); and March of Dimes Foundation Grant 6-FY15-254 (to S.S.W.).
S.S.W. holds a Pathogenesis of Infectious Disease Award (#1011031) from the
Burroughs Wellcome Fund.
Received: July 25, 2016
Revised: September 25, 2016
Accepted: October 13, 2016
Published: November 8, 2016
REFERENCES
Anderson, M.S., and Bluestone, J.A. (2005). The NOD mouse: a model of
immune dysregulation. Annu. Rev. Immunol. 23, 447–485.
Anderson, M.S., Venanzi, E.S., Chen, Z., Berzins, S.P., Benoist, C., and
Mathis, D. (2005). The cellular mechanism of Aire control of T cell tolerance.
Immunity 23, 227–239.
Ansari, M.J.I., Salama, A.D., Chitnis, T., Smith, R.N., Yagita, H., Akiba, H., Ya-
mazaki, T., Azuma, M., Iwai, H., Khoury, S.J., et al. (2003). The programmed
death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic
(NOD) mice. J. Exp. Med. 198, 63–69.
Barber, D.L., Wherry, E.J., Masopust, D., Zhu, B., Allison, J.P., Sharpe, A.H.,
Freeman, G.J., and Ahmed, R. (2006). Restoring function in exhausted CD8
T cells during chronic viral infection. Nature 439, 682–687.
Bautista, J.L., Lio, C.-W.J., Lathrop, S.K., Forbush, K., Liang, Y., Luo, J., Ru-
densky, A.Y., and Hsieh, C.-S. (2009). Intraclonal competition limits the fate
determination of regulatory T cells in the thymus. Nat. Immunol. 10, 610–617.1792 Cell Reports 17, 1783–1794, November 8, 2016Bettini, M., Blanchfield, L., Castellaw, A., Zhang, Q., Nakayama, M., Smeltzer,
M.P., Zhang, H., Hogquist, K.A., Evavold, B.D., and Vignali, D.A.A. (2014). TCR
affinity and tolerance mechanisms converge to shape T cell diabetogenic
potential. J. Immunol. 193, 571–579.
Carter, L.L., Leach, M.W., Azoitei, M.L., Cui, J., Pelker, J.W., Jussif, J., Benoit,
S., Ireland, G., Luxenberg, D., Askew, G.R., et al. (2007). PD-1/PD-L1, but not
PD-1/PD-L2, interactions regulate the severity of experimental autoimmune
encephalomyelitis. J. Neuroimmunol. 182, 124–134.
Chan, J., Ban, E.J., Chun, K.H., Wang, S., Ba¨ckstro¨m, B.T., Bernard, C.C.,
Toh, B.H., and Alderuccio, F. (2008). Transplantation of bone marrow trans-
duced to express self-antigen establishes deletional tolerance and perma-
nently remits autoimmune disease. J. Immunol. 181, 7571–7580.
Cheng, X., Zhao, Z., Ventura, E., Gran, B., Shindler, K.S., and Rostami, A.
(2007). The PD-1/PD-L pathway is up-regulated during IL-12-induced sup-
pression of EAE mediated by IFN-gamma. J. Neuroimmunol. 185, 75–86.
Day, C.L., Kaufmann, D.E., Kiepiela, P., Brown, J.A., Moodley, E.S., Reddy, S.,
Mackey, E.W., Miller, J.D., Leslie, A.J., DePierres, C., et al. (2006). PD-1
expression on HIV-specific T cells is associatedwith T-cell exhaustion and dis-
ease progression. Nature 443, 350–354.
Delarasse, C., Daubas, P., Mars, L.T., Vizler, C., Litzenburger, T., Iglesias, A.,
Bauer, J., Della Gaspera, B., Schubart, A., Decker, L., et al. (2003). Myelin/
oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of
immune tolerance to MOG in wild-type mice. J. Clin. Invest. 112, 544–553.
Ertelt, J.M., Rowe, J.H., Johanns, T.M., Lai, J.C., McLachlan, J.B., and Way,
S.S. (2009). Selective priming and expansion of antigen-specific Foxp3
CD4+ T cells during Listeria monocytogenes infection. J. Immunol. 182,
3032–3038.
Fife, B.T., Kennedy, K.J., Paniagua, M.C., Lukacs, N.W., Kunkel, S.L., Luster,
A.D., and Karpus, W.J. (2001). CXCL10 (IFN-g-inducible protein-10) control of
encephalitogenic CD4+ T cell accumulation in the central nervous system
during experimental autoimmune encephalomyelitis. J. Immunol. 166, 7617–
7624.
Garon, E.B., Rizvi, N.A., Hui, R., Leighl, N., Balmanoukian, A.S., Eder, J.P., Pat-
naik, A., Aggarwal, C., Gubens, M., Horn, L., et al.; KEYNOTE-001 Investiga-
tors (2015). Pembrolizumab for the treatment of non-small-cell lung cancer.
N. Engl. J. Med. 372, 2018–2028.
Gro¨nberg, H. (2003). Prostate cancer epidemiology. Lancet 361, 859–864.
Hale, J.S., Boursalian, T.E., Turk, G.L., and Fink, P.J. (2006). Thymic output in
aged mice. Proc. Natl. Acad. Sci. USA 103, 8447–8452.
Hsieh, C.-S., Zheng, Y., Liang, Y., Fontenot, J.D., and Rudensky, A.Y. (2006).
An intersection between the self-reactive regulatory and nonregulatory T cell
receptor repertoires. Nat. Immunol. 7, 401–410.
Huseby, E.S., Sather, B., Huseby, P.G., and Goverman, J. (2001). Age-depen-
dent T cell tolerance and autoimmunity to myelin basic protein. Immunity 14,
471–481.
Jordan, M.S., Boesteanu, A., Reed, A.J., Petrone, A.L., Holenbeck, A.E., Ler-
man, M.A., Naji, A., and Caton, A.J. (2001). Thymic selection of CD4+CD25+
regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2,
301–306.
Judkowski, V., Pinilla, C., Schroder, K., Tucker, L., Sarvetnick, N., and Wilson,
D.B. (2001). Identification of MHC class II-restricted peptide ligands, including
a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic
T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166,
908–917.
Kalekar, L.A., Schmiel, S.E., Nandiwada, S.L., Lam, W.Y., Barsness, L.O.,
Zhang, N., Stritesky, G.L., Malhotra, D., Pauken, K.E., Linehan, J.L., et al.
(2016). CD4+ T cell anergy prevents autoimmunity and generates regulatory
T cell precursors. Nat. Immunol. 17, 304–314.
Kappler, J.W., Roehm, N., and Marrack, P. (1987). T cell tolerance by clonal
elimination in the thymus. Cell 49, 273–280.
Kinder, J.M., Jiang, T.T., Ertelt, J.M., Xin, L., Strong, B.S., Shaaban, A.F., and
Way, S.S. (2015). Cross-generational reproductive fitness enforced by micro-
chimeric maternal cells. Cell 162, 505–515.
Kisielow, P., Bl€uthmann, H., Staerz, U.D., Steinmetz, M., and von Boehmer, H.
(1988). Tolerance in T-cell-receptor transgenic mice involves deletion of non-
mature CD4+8+ thymocytes. Nature 333, 742–746.
Kroner, A., Mehling, M., Hemmer, B., Rieckmann, P., Toyka, K.V., Ma¨urer, M.,
and Wiendl, H. (2005). A PD-1 polymorphism is associated with disease pro-
gression in multiple sclerosis. Ann. Neurol. 58, 50–57.
Kurts, C., Kosaka, H., Carbone, F.R., Miller, J.F.A.P., and Heath, W.R. (1997).
Class I-restricted cross-presentation of exogenous self-antigens leads to
deletion of autoreactive CD8+ T cells. J. Exp. Med. 186, 239–245.
Lee, H.-M., Bautista, J.L., Scott-Browne, J., Mohan, J.F., and Hsieh, C.-S.
(2012). A broad range of self-reactivity drives thymic regulatory T cell selection
to limit responses to self. Immunity 37, 475–486.
Legoux, F.P., Lim, J.-B., Cauley, A.W., Dikiy, S., Ertelt, J., Mariani, T.J., Spar-
wasser, T., Way, S.S., and Moon, J.J. (2015). CD4+ T cell tolerance to tissue-
restricted self antigens ismediated by antigen-specific regulatory T cells rather
than deletion. Immunity 43, 896–908.
Leslie, R.D.G., and Delli Castelli, M. (2004). Age-dependent influences on the
origins of autoimmune diabetes: evidence and implications. Diabetes 53,
3033–3040.
Leung, M.W.L., Shen, S., and Lafaille, J.J. (2009). TCR-dependent differentia-
tion of thymic Foxp3+ cells is limited to small clonal sizes. J. Exp. Med. 206,
2121–2130.
Maeda, Y., Nishikawa, H., Sugiyama, D., Ha, D., Hamaguchi, M., Saito, T.,
Nishioka, M., Wing, J.B., Adeegbe, D., Katayama, I., and Sakaguchi, S.
(2014). Detection of self-reactive CD8+ T cells with an anergic phenotype in
healthy individuals. Science 346, 1536–1540.
Malhotra, D., Linehan, J.L., Dileepan, T., Lee, Y.J., Purtha, W.E., Lu, J.V.,
Nelson, R.W., Fife, B.T., Orr, H.T., Anderson, M.S., et al. (2016). Tolerance is
established in polyclonal CD4+ T cells by distinct mechanisms, according to
self-peptide expression patterns. Nat. Immunol. 17, 187–195.
Martinez, R.J., Zhang, N., Thomas, S.R., Nandiwada, S.L., Jenkins, M.K., Bin-
stadt, B.A., and Mueller, D.L. (2012). Arthritogenic self-reactive CD4+ T cells
acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory
T cells. J. Immunol. 188, 170–181.
Mathis, D., and Benoist, C. (2009). Aire. Annu. Rev. Immunol. 27, 287–312.
Mayr, W.T., Pittock, S.J., McClelland, R.L., Jorgensen, N.W., Noseworthy,
J.H., and Rodriguez, M. (2003). Incidence and prevalence of multiple sclerosis
in Olmsted County, Minnesota, 1985–2000. Neurology 61, 1373–1377.
Miller, S.D., and Karpus, W.J. (2007). Experimental autoimmune encephalo-
myelitis in the mouse. Curr. Protoc. Immunol. Chapter 15, Unit 15.1.
Moon, J.J., Chu, H.H., Pepper, M., McSorley, S.J., Jameson, S.C., Kedl, R.M.,
and Jenkins, M.K. (2007). Naive CD4+ T cell frequency varies for different epi-
topes and predicts repertoire diversity and response magnitude. Immunity 27,
203–213.
Moon, J.J., Dash, P., Oguin, T.H., 3rd, McClaren, J.L., Chu, H.H., Thomas,
P.G., and Jenkins, M.K. (2011). Quantitative impact of thymic selection on
Foxp3+ and Foxp3 subsets of self-peptide/MHC class II-specific CD4+
T cells. Proc. Natl. Acad. Sci. USA 108, 14602–14607.
Nakamoto, N., Kaplan, D.E., Coleclough, J., Li, Y., Valiga, M.E., Kaminski, M.,
Shaked, A., Olthoff, K., Gostick, E., Price, D.A., et al. (2008). Functional resto-
ration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1
expression and compartmentalization. Gastroenterology 134, 1927–1937,
1937.e1–1937.e2.
Nelson, R.W., Beisang, D., Tubo, N.J., Dileepan, T., Wiesner, D.L., Nielsen, K.,
W€uthrich, M., Klein, B.S., Kotov, D.I., Spanier, J.A., et al. (2015). T cell receptor
cross-reactivity between similar foreign and self peptides influences naive cell
population size and autoimmunity. Immunity 42, 95–107.
Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999). Develop-
ment of lupus-like autoimmune diseases by disruption of the PD-1 gene en-
coding an ITIM motif-carrying immunoreceptor. Immunity 11, 141–151.
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A.,
Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., and Honjo, T. (2001).Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science
291, 319–322.
Odorizzi, P.M., Pauken, K.E., Paley, M.A., Sharpe, A., and Wherry, E.J. (2015).
Genetic absence of PD-1 promotes accumulation of terminally differentiated
exhausted CD8+ T cells. J. Exp. Med. 212, 1125–1137.
Pauken, K.E., Linehan, J.L., Spanier, J.A., Sahli, N.L., Kalekar, L.A., Binstadt,
B.A., Moon, J.J., Mueller, D.L., Jenkins, M.K., and Fife, B.T. (2013). Cutting
edge: type 1 diabetes occurs despite robust anergy among endogenous insu-
lin-specific CD4 T cells in NOD mice. J. Immunol. 191, 4913–4917.
Probst, H.C., McCoy, K., Okazaki, T., Honjo, T., and van den Broek, M. (2005).
Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1
and CTLA-4. Nat. Immunol. 6, 280–286.
Prokunina, L., Castillejo-Lo´pez, C., O¨berg, F., Gunnarsson, I., Berg, L., Mag-
nusson, V., Brookes, A.J., Tentler, D., Kristjansdo´ttir, H., Gro¨ndal, G., et al.
(2002). A regulatory polymorphism in PDCD1 is associated with susceptibility
to systemic lupus erythematosus in humans. Nat. Genet. 32, 666–669.
Rangachari, M., and Kuchroo, V.K. (2013). Using EAE to better understand
principles of immune function and autoimmune pathology. J. Autoimmun.
45, 31–39.
Rees, W., Bender, J., Teague, T.K., Kedl, R.M., Crawford, F., Marrack, P., and
Kappler, J. (1999). An inverse relationship between T cell receptor affinity and
antigen dose during CD4+ T cell responses in vivo and in vitro. Proc. Natl.
Acad. Sci. USA 96, 9781–9786.
Robert, C., Schachter, J., Long, G.V., Arance, A., Grob, J.J., Mortier, L., Daud,
A., Carlino, M.S., McNeil, C., Lotem, M., et al.; KEYNOTE-006 Investigators
(2015). Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl.
J. Med. 372, 2521–2532.
Rui, Y., Honjo, T., and Chikuma, S. (2013). Programmed cell death 1 inhibits
inflammatory helper T-cell development through controlling the innate immune
response. Proc. Natl. Acad. Sci. USA 110, 16073–16078.
Salama, A.D., Chitnis, T., Imitola, J., Ansari, M.J.I., Akiba, H., Tushima, F.,
Azuma, M., Yagita, H., Sayegh, M.H., and Khoury, S.J. (2003). Critical role of
the programmed death-1 (PD-1) pathway in regulation of experimental autoim-
mune encephalomyelitis. J. Exp. Med. 198, 71–78.
Schietinger, A., Delrow, J.J., Basom, R.S., Blattman, J.N., and Greenberg,
P.D. (2012). Rescued tolerant CD8 T cells are preprogrammed to reestablish
the tolerant state. Science 335, 723–727.
Schmidt, E.M., Wang, C.J., Ryan, G.A., Clough, L.E., Qureshi, O.S., Goodall,
M., Abbas, A.K., Sharpe, A.H., Sansom, D.M., and Walker, L.S.K. (2009).
Ctla-4 controls regulatory T cell peripheral homeostasis and is required for
suppression of pancreatic islet autoimmunity. J. Immunol. 182, 274–282.
Schreiner, B., Bailey, S.L., Shin, T., Chen, L., and Miller, S.D. (2008). PD-1
ligands expressed on myeloid-derived APC in the CNS regulate T-cell re-
sponses in EAE. Eur. J. Immunol. 38, 2706–2717.
Shimatani, K., Nakashima, Y., Hattori, M., Hamazaki, Y., andMinato, N. (2009).
PD-1+ memory phenotype CD4+ T cells expressing C/EBPalpha underlie T cell
immunodepression in senescence and leukemia. Proc. Natl. Acad. Sci. USA
106, 15807–15812.
Taswell, C. (1981). Limiting dilution assays for the determination of immuno-
competent cell frequencies. I. Data analysis. J. Immunol. 126, 1614–1619.
Topalian, S.L., Hodi, F.S., Brahmer, J.R., Gettinger, S.N., Smith, D.C.,
McDermott, D.F., Powderly, J.D., Carvajal, R.D., Sosman, J.A., Atkins, M.B.,
et al. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in
cancer. N. Engl. J. Med. 366, 2443–2454.
Tubo, N.J., Paga´n, A.J., Taylor, J.J., Nelson, R.W., Linehan, J.L., Ertelt, J.M.,
Huseby, E.S., Way, S.S., and Jenkins, M.K. (2013). Single naive CD4+ T cells
from a diverse repertoire produce different effector cell types during infection.
Cell 153, 785–796.
Utzschneider, D.T., Legat, A., Fuertes Marraco, S.A., Carrie´, L., Luescher, I.,
Speiser, D.E., and Zehn, D. (2013). T cells maintain an exhausted phenotype
after antigen withdrawal and population reexpansion. Nat. Immunol. 14,
603–610.Cell Reports 17, 1783–1794, November 8, 2016 1793
Walker, L.S.K., Chodos, A., Eggena, M., Dooms, H., and Abbas, A.K. (2003).
Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo.
J. Exp. Med. 198, 249–258.
Wang, J., Yoshida, T., Nakaki, F., Hiai, H., Okazaki, T., and Honjo, T. (2005).
Establishment of NOD-Pdcd1/ mice as an efficient animal model of type I
diabetes. Proc. Natl. Acad. Sci. USA 102, 11823–11828.
Yamazaki, T., Akiba, H., Iwai, H., Matsuda, H., Aoki, M., Tanno, Y., Shin, T.,
Tsuchiya, H., Pardoll, D.M., Okumura, K., et al. (2002). Expression of pro-1794 Cell Reports 17, 1783–1794, November 8, 2016grammed death 1 ligands by murine T cells and APC. J. Immunol. 169,
5538–5545.
Zhu, B., Guleria, I., Khosroshahi, A., Chitnis, T., Imitola, J., Azuma, M., Yagita,
H., Sayegh, M.H., and Khoury, S.J. (2006). Differential role of programmed
death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility
and chronic progression of experimental autoimmune encephalomyelitis.
J. Immunol. 176, 3480–3489.
